Maria Del Barrio

Santander, CB, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Steatotic Liver Disease at Primary Biliary Cholangitis Diagnosis: Association With Ursodeoxycholic Acid Response and Outcomes.

Steatotic Liver Disease at Primary Biliary Cholangitis Diagnosis: Association With Ursodeoxycholic Acid Response and Outcomes.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: November 09, 2025

Primary Biliary Cholangitis: Immunopathogenesis and the Role of Bile Acid Metabolism in Disease Progression.

Primary Biliary Cholangitis: Immunopathogenesis and the Role of Bile Acid Metabolism in Disease Progression.

Journal: International journal of molecular sciences

Published: June 08, 2025

Unveiling Drug-Induced Autoimmune-Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study.

Unveiling Drug-Induced Autoimmune-Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study.

Journal: Alimentary pharmacology & therapeutics

Published: May 01, 2025

Occurrence and Management of Opportunistic Infections in Patients With Autoimmune Hepatitis: A Spanish Multicentre Study.

Occurrence and Management of Opportunistic Infections in Patients With Autoimmune Hepatitis: A Spanish Multicentre Study.

Journal: Alimentary pharmacology & therapeutics

Published: January 03, 2025

Liver stiffness measurement predicts clinical outcomes in autoimmune hepatitis.

Liver stiffness measurement predicts clinical outcomes in autoimmune hepatitis.

Journal: JHEP reports : innovation in hepatology

Published: May 03, 2024

Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease.

Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease.

Journal: Journal of hepatology

Published: November 25, 2023

Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key.

Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key.

Journal: International journal of molecular sciences

Published: April 27, 2023

Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review.

Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review.

Journal: International journal of molecular sciences

Published: February 21, 2023

Faecal Microbiota Transplantation, Paving the Way to Treat Non-Alcoholic Fatty Liver Disease.

Faecal Microbiota Transplantation, Paving the Way to Treat Non-Alcoholic Fatty Liver Disease.

Journal: International journal of molecular sciences

Published: February 15, 2023

Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.

Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.

Journal: Hepatology (Baltimore, Md.)

Published: May 05, 2022

SARS-CoV-2 and Liver Transplant: How Has It Behaved in This Sixth Wave?

SARS-CoV-2 and Liver Transplant: How Has It Behaved in This Sixth Wave?

Journal: Transplantation

Published: April 08, 2022

Immune Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Liver Transplant Recipients.

Immune Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Liver Transplant Recipients.

Journal: Transplantation

Published: March 24, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026